Agulló, C.; Puig, N.; Contreras, T.; Castro, S.; Puertas, B.; González-Calle, V.; Rey-Búa, B.; Mateos, M.V.
Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma. Biomedicines 2024, 12, 1153.
https://doi.org/10.3390/biomedicines12061153
AMA Style
Agulló C, Puig N, Contreras T, Castro S, Puertas B, González-Calle V, Rey-Búa B, Mateos MV.
Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma. Biomedicines. 2024; 12(6):1153.
https://doi.org/10.3390/biomedicines12061153
Chicago/Turabian Style
Agulló, Cristina, Noemà Puig, Teresa Contreras, Sergio Castro, Borja Puertas, Verónica González-Calle, Beatriz Rey-Búa, and MarÃa Victoria Mateos.
2024. "Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma" Biomedicines 12, no. 6: 1153.
https://doi.org/10.3390/biomedicines12061153
APA Style
Agulló, C., Puig, N., Contreras, T., Castro, S., Puertas, B., González-Calle, V., Rey-Búa, B., & Mateos, M. V.
(2024). Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma. Biomedicines, 12(6), 1153.
https://doi.org/10.3390/biomedicines12061153
